A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

Sep. 9, 2024 — Researchers tested a preclinical model for an experimental gene therapy designed to treat multiple sulfatase deficiency (MSD), a disorder that affects the brain, lungs ...

Researcher creates a groundbreaking genetic model for breast cancer, offering new insights and potential advances in ...

A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...

The researchers will explore non-viral options for delivering gene therapy to potential DMD patients, specifically ...

Sarepta Therapeutics SRPT posted third-quarter 2024 adjusted earnings per share (EPS) of 62 cents, which beat the Zacks ...

In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...

IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition's pathogenesis.

New legislation would clarify rules around value-based contracts in Medicaid, and a new model is expanding access to gene therapies, explained Adam Colborn, JD, of AMCP.

Purespring’s gene therapy, PS-002, uses a viral vector to target kidney cells—known as podocytes—to treat IgA nephropathy, a ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

The gene therapy landscape has changed dramatically ... Building on prior research, a team tackled mouse-model colon cancer with a novel nonviral nanovector to carry dual–messenger RNA (mRNA ...